Background
Sonic hedgehog (Shh) is a secreted protein known to function in the patterning of multiple regions of the embryo, including the dorsoventral axis of the nervous system [1] , sclerotome formation in the somites [2] , and anteroposterior patterning of the limbs [3] . Shh gene mutations have been described in both mouse [4] and human [5] . Moreover, the targeted disruption of Shh in mouse is lethal at or around birth. In addition to loss of the ventral neural tube throughout the neuraxis, there are significant defects in head development in these Shh mutants. Facial structures that are normally bilateral are fused and the branchial arches, which are outgrowths of the head that contain endoderm, ectoderm, mesoderm and neural crest cells, fail to develop. By embryonic day 15.5, the face is reduced to a single fused structure in the midline [4] . Point mutations in the human SHH gene have been linked to holoprosencephaly, a heterogeneous disorder characterized by perturbations in the development of the forebrain and midline of the face [5] . It is unclear, however, whether the loss of head structures that occurs when Shh is mutated is due to loss of Shh expression in the ectoderm and endoderm of the developing head or is secondary to defects in the neural tube.
Neural crest cells play a central role in establishing and patterning the head of the developing embryo. Neural crest cells migrate from the dorsal neural tube, through the cranial mesenchyme and into the branchial arches. They contribute to formation of the forebrain meninges, cranial sensory ganglia and some of the skull [6] ; those cells that enter the branchial arches contribute to formation of the bones of the jaw [7] . Ablation of the dorsal neural tube, just before neural crest cell migration, greatly reduces the number of cranial neural crest cells. Interestingly, embryos that are depleted of neural crest cells have a phenotype similar to that of embryos with reduced Shh signaling, including defects in the forebrain, cyclopia or microopthalmia, and reduced size or absence of jaw structures derived from the neural crest [8] [9] [10] . No direct relationship between neural crest cells and Shh signaling has yet been described, however. In fact, aside from its role in dorsoventral patterning of the cranial neural tube, the role of Shh in the development of the head remains unclear.
In addition to its expression in the notochord and floorplate, Shh is expressed in a precise pattern in the ectoderm and endoderm of the developing branchial arches during 
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Background: Sonic hedgehog (Shh) is well known for its role in patterning tissues, including structures of the head. Haploinsufficiency for SHH in humans results in holoprosencephaly, a syndrome characterized by facial and forebrain abnormalities. Shh null mice have cyclopia and loss of branchial arch structures. It is unclear, however, whether these phenotypes arise solely from the early function of Shh in patterning midline structures, or whether Shh plays other roles in head development.
Results:
To address the role of Shh after floorplate induction, we inhibited Shh signaling by injecting hybridoma cells that secrete a function-blocking anti-Shh antibody into the chick cranial mesenchyme. The antibody subsequently bound to Shh in the floorplate, notochord, and the pharyngeal endoderm. Perturbation of Shh signaling at this stage resulted in a significant reduction in head size after 1 day, loss of branchial arch structures after 2 days, and embryos with smaller heads after 7 days. Cell death was significantly increased in the neural tube and neural crest after 1 day, and neural crest cell death was not secondary to the loss of neural tube cells.
Conclusions:
Reduction of Shh signaling after neural tube closure resulted in a transient decrease in neural tube cell proliferation and an extensive increase in cell death in the neural tube and neural crest, which in turn resulted in decreased head size. The phenotypes observed after reduction of Shh are similar to those observed after cranial neural crest ablation. Thus, our results demonstrate a role for Shh in coordinating the proliferation and survival of cells of the neural tube and cranial neural crest.
neural crest cell migration. Shh has been proposed to play a role in pattern formation of the branchial arches that is similar to its function in limb development [11, 12] . In the Shh mutant mouse, the branchial arches are lost [4] , and in chick embryos treated with alkaloids that block Shh signaling, branchial arches are reduced [13, 14] . Because both of these approaches remove Shh signaling before ventralization of the neural tube, the mechanism of loss of branchial arch structures could be due either to the loss of an inductive event, similar or identical to the induction of floorplate, or could reflect a continuous requirement for Shh in directing the patterning and/or growth of the branchial arches. To distinguish between these two possibilities, it is necessary to block Shh signaling at a later stage, after the initial induction of floorplate.
In order to examine the role of Shh in head patterning subsequent to its role in patterning the neural tube, we used antibody-mediated perturbation of Shh function during branchial arch formation and population by migrating neural crest cells. We found that a reduction of Shh signaling had severe consequences on head growth and morphology. In particular, there was a reduction in the survival of neural tube and neural crest cells, which led to a loss of branchial arch structures and reduced head size.
Results
Shh expression in the head during cranial neural crest cell migration
The pattern of Shh expression in the developing chick head has been described previously [12] . Shh transcripts are located in the floorplate cells of the neural tube as well as in the axial mesoderm (prechordal mesoderm and notochord), which underlies the floorplate (Figure 1a ,h, Figure 2 ). By developmental stage 12, Shh expression begins in the lateral pockets of the pharyngeal endoderm, which grow out to meet the ectoderm and form the branchial arches (Figure 1a -c,h-i, Figure 2d ,f). After 3 days of incubation (stages [15] [16] [17] [18] [19] , Shh expression is strong in the branchial arches, but is restricted to specific patterns in each branchial arch, and is confined to the ectoderm or endoderm (Figure 1d,f, Figure 2 ). The pattern of expression of Patched (Ptc), the gene encoding the transmembrane receptor for Shh, is similar to that of Shh at this stage (Figure 1e,g ), except that the expression domain extends from the epithelium into adjacent mesenchymal cells.
Cranial neural crest cells arise at a distance from the floorplate and actively avoid the notochord during migration [15] ; subsequently, these cells migrate past the Shh-expressing areas of the endoderm (Figures 1h,i) . The HNK-1 antibody recognized a population of migratory neural crest cells en route to the branchial arches (Figure 1h ), but this epitope was downregulated as the cells approached the pharyngeal endoderm and entered the arch. To verify that neural crest cells approach the pharyngeal endoderm, we used quail-to-chick neural tube grafts to visualize neural crest cells in the later stages of migration. The hindbrain of a seven-somite host chick embryo (stage 9) was replaced with a donor hindbrain from a quail embryo at the same stage; migrating neural crest cells were recognized using the quail-specific nuclear antibody, QCPN. By stage 14, quail neural crest cells were observed migrating past the Shh-positive pharyngeal endoderm (Figure 1i ).
Antibody-mediated inhibition of Shh signaling in the chick head
We have previously shown that injection of hybridoma cells into the head provides an efficient and continuous source of function-perturbing antibody [16] . To test the role of Shh in head patterning subsequent to its role in floorplate specification and division of the eye field, we introduced hybridoma cells (line 5E1) that block the function of Shh [17] into the mesenchyme lateral to the hindbrain of embryos at stage 9-11 ( Figure 2a ). This resulted in a continuous source of anti-Shh antibody. A quail-specific antibody, QCPN, which has the same isotype, was used as a control. This antibody recognizes a perinuclear antigen present only in quail cells, and does not crossreact with chick cells (Figure 2e,g ). Injection of anti-Shh hybridoma cells into the lateral mesenchyme allowed diffusion of the antibody throughout the head of the embryo, including access to the floorplate and endoderm (Figure 2d ).
The production and spread of the antibody as a function of time was visualized using alkaline-phosphatase-conjugated secondary antibody (Figure 2 ). The antibody strongly labeled Shh-expressing tissues, such as notochord, floorplate, and pharyngeal endoderm, and lightly labeled adjacent tissues known to express the Shh receptor Ptc, such as the ventral and intermediate neural tube (Figure 2f ). The injected hybridoma cells survived and proliferated (as judged by intact nuclei and BrdU incorporation, respectively; data not shown). No apparent differences were noted between unilateral and bilateral injections, nor were there any apparent differences in the hybridoma survival and proliferation between the control and experimental hybridoma lines (data not shown).
The pattern of antibody labeling was reproducible as a function of time after injection. Two hours after injection, the floorplate of the hindbrain was consistently labeled adjacent to the injected cells ( Figures 2b,c) ; by 6 hours after injection, the ventral midline, notochord and prechordal mesoderm throughout the head were labeled. This suggests that the antibody diffuses and interacts with all Shh-producing sites in the head. In contrast to injections into the cranial mesenchyme lateral to the neural tube, hybridoma cells introduced into the lumen of the neural tube yielded staining that was confined to the floorplate (see later). This suggests that the antibody cannot cross the neural tube basement membrane when introduced lumenally.
Shh transcripts are expressed in the pharyngeal endoderm by ~stage 12, which corresponds to 9-15 hours after injection. Consistent with this, labeling of the endoderm with anti-Shh antibody was observed only after 12 hours (data not shown). Robust labeling in the endoderm and ectoderm of the branchial arch was observed 1 day after injection (Figures 2d,f) . The cells producing the anti-Shh antibody typically resided within the cranial mesenchyme, but were occasionally found in the lumen of the developing pharynx (Figure 2c ). In contrast to anti-Shh hybridoma, control injections resulted in labeling of no structures other than the hybridoma cells themselves (Figures 2e,g ).
Developmental abnormalities after injection of anti-Shh antibody
Both anti-Shh-treated and control embryos had developed the same number of somites when examined at 6 and 24 hours after injection (Table 1 ). In contrast, profound changes were observed in the progression of head development by one day post-injection. . Branchial arch formation was abnormal in anti-Shh-treated embryos, and an analysis of head size 24 hours after treatment revealed a significant size reduction of ~17-20% of anti-Shh-treated embryos compared with control embryos (p < 0.05 in three experiments, Student's t-test; n = 35 and 28 for anti-Shh and control embryos, respectively; Figure 3a-c).
There was a reduction in overall embryonic development in anti-Shh-treated embryos compared with control embryos 48 hours after hybridoma injection. By this stage, the expressed antibody had diffused throughout the embryo (data not shown). Many embryos appeared abnormal or drastically delayed developmentally compared to controls (Figure 3d ,e), but there was no increase in embryonic mortality. The extensive abnormalities made it difficult to accurately compare head size between experimental groups. Therefore, embryos were categorized on the basis of the state of their developmental progression. Although branchial arch morphology appeared grossly normal 24 hours after injection of hybridoma cells, a significant percentage of the neural crest cells that normally populate branchial arches did not survive in the absence of Shh signaling (see below). This eventually resulted in regression or arrest of branchial arch development, such that a high percentage of embryos had a readily identifiable phenotype that consisted of reduced or missing branchial arch structures and reduced frontonasal tissue when compared to age-matched control embryos (Figure 3d ). The forebrain exhibited particularly poor development. The percentage of embryos with these abnormal phenotypes was significantly higher after anti-Shh treatment (n = 44) compared with control (n = 36; χ 2 = 10.834, p < 0.05; Figure 3d ).
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Time after hybridoma injection Number of somites added
Anti-Shh Control 6 h* 2.5 ± 0.2 (n = 6) 2.7 ± 0.3 (n = 6) 24 h* 16.9 ± 0.4 (n = 8) 17.6 ± 0.3 (n = 12)
The asterisks indicate a probability (p) of > 0.05. Long-term embryonic survival after hybridoma treatment was low regardless of the hybridoma cell type used (data not shown). Increases in mortality began on the third day after hybridoma injection, presumably because of an overproliferation of the hybridoma cells or a toxic effect of having hybridoma cells in the developing embryo (3 days after injection, 23.5% of control embryos were alive, compared with 23.7% of anti-Shh-treated embryos).
Some embryos (< 5%) survived for up to 7 days after injection. These embryos appeared to have normal patterning of the cartilaginous skeleton (n = 4; data not shown), although head size was reduced in antiShh-injected embryos, compared with control-injected embryos (Figure 3f,g ). Of twelve anti-Shh embryos, two had severe holoprosencephaly, but not cyclopia (Figure 3h ,i), whereas surviving control embryos displayed no abnormalities (Figure 3f ). Embryos with severe brain and eye phenotypes possessed upper and lower jaws that were normally patterned but reduced in size (Figure 3h ), which is consistent with the findings that loss of neural crest cells in this region was not complete, as suggested by the analysis of cell death one day after injection (see below).
Analysis of cell proliferation after antibody injection
Shh is thought to play multiple roles in cell proliferation and differentiation [18] [19] [20] [21] . The reduced head size after anti-Shh treatment could be due to decreased proliferation and/or increased cell death. To determine whether antiShh treatment affects cell proliferation, embryos were exposed to BrdU for 1 hour at two different times after injection. A reduction in BrdU labeling of ventral neural tube cells was observed 6 hours after anti-Shh hybridoma injection in seven out of nine embryos (data not shown). This effect was confined to cells in the immediate vicinity of the injected hybridoma cells. In contrast, other regions of the neural tube within the same section did not appear to be affected. The proliferation of cells in the mesenchyme, even those adjacent to hybridoma cells, also appeared to be unaffected. In contrast to anti-Shh-treated embryos, no change in proliferation was seen in twelve control embryos examined (see Supplementary material).
This initial reduction in proliferation of neural tube cells was transient and was not maintained in embryos examined 1 day after treatment with anti-Shh hybridoma cells, when no significant differences were observed in the percentage of BrdU-positive cells in anti-Shh-treated, compared with control embryos ( Table 2 ). The transient and localized decrease in proliferation within the neural tube 6 hours after injection appears to be insufficient to account for the smaller head size in anti-Shh-treated embryos.
Analysis of cell death after hybridoma injection
Another mechanism that can result in fewer cells and smaller tissues is cell death, either due to active killing as observed in the thymus, or apoptosis in response to limited amounts of survival factors. Cell death was examined in whole embryos using the membrane-impermeable dye benzothiazolium-4-quinolium (TO-PRO-1) [22] . Only a minor amount of cell death, scattered throughout the head, was seen in control embryos (Figure 4c ). But, extensive cell death was observed 24 hours after treatment with anti-Shh hybridoma (Figure 4a,b) . The pattern of dying cells was reminiscent of migratory streams of neural crest cells around the otic vesicle.
To examine cell death at the level of individual cells, sections were exposed to the nuclear stain 4′,6-diamidino-2-phenylindole (DAPI) [23] . Live cells had diffuse nuclear staining after DAPI staining, whereas dead cells had condensed, bright staining (Figure 4d-g,5) . Separate sections were stained using the TUNEL method, which confirmed that the pyknotic nuclei seen with DAPI are also TUNELpositive (data not shown). No differences in the amount of cell death were observed in anti-Shh-treated embryos examined 6 hours after injection, compared with control embryos (data not shown). When examined 24 hours after injection, increased cell death in both the neural tube ( Figure 4f ) and the mesenchyme (Figure 4d ) was seen in anti-Shh-treated embryos compared with control embryos (Figure 4e,g ). In contrast, no increase in cell death was seen in the adjacent ectoderm, notochord, and the otic vesicle (Figure 4d ). The percentage of dead cells in the neural tube in anti-Shh-treated embryos was significantly greater than in control embryos (5.7 ± 1.6%, n = 37 compared with 0.4 ± 0.2, n = 30; p < 0.05).
Many dying cells within the cranial mesenchyme are of neural crest origin
To determine whether the dead cells in the mesenchyme are of neural crest origin, embryonic sections were stained with the HNK-1 antibody, which labels the majority of cranial neural crest cells during the early stages of their migration. In contrast to cranial neural crest cells, cranial mesenchyme cells are HNK-1-negative Table 2 BrdU incorporation after 24 h of hybridoma treatment.
BrdU-positive cells (%)
Anti-Shh Control Mesenchyme* 46.0 ± 1.7 (n = 76) 51.8 ± 2.5 (n = 28)
Neural tube* 46.1 ± 2.0 (n = 37) 45.5 ± 2.3 (n = 26)
The asterisks indicate a probability (p) of > 0.05; numbers in parentheses refer to the number of sections examined; twelve antiShh-treated embryos and six control embryos were examined. Figures 4a,b) ; second, the observation that the cell membranes of dying cells stained with the HNK-1 antibody ( Figure 5) ; and third, the paucity of dying cells in regions without neural crest cells ( Figure 5 ).
Relationship between cell death in the neural tube and cell death in the neural crest
Because cell death was seen in both the neural tube and the neural crest, it was germane to ask whether neural crest cell death was secondary to cell death in the neural tube. To this end, we examined neural crest cell survival under two different circumstances: after ablation of the dorsal or the entire neural tube; and after injection of anti-Shh hybridoma cells into the neural tube lumen, which blocks Shh in the neural tube but not in the notochord or endoderm. four embryos; compare with Figure 5c ). Thus, cell death in the dorsal neural tube is separable from cell death in the migrating neural crest cell population, suggesting that neural crest cells are not dying as a secondary consequence of cell death in the dorsal neural tube. Consistent with this, head size was not altered under these conditions. The average distance between the otic vesicle and midbrain was 1.59 ± 0.092 mm (n = 9) in anti-Shh-treated embryos compared with 1.58 ± 0.086 mm (n = 28) in control embryos. Similarly, the average distance between the nose and hindbrain was 1.83 ± 0.086 mm (n = 9) in antiShh-treated embryos compared with 1.81 ± 0.094 mm (n = 28) in the controls. Taken together with the ablation experiments, these results indicate that the absence of the neural tube (by ablation) or cell death (after hybridoma injection) can account for only a small part of the survival signal initiated by Shh, which ultimately affects migrating neural crest cells. In addition, the normal head size observed after injection of hybridoma cells into the neural tube indicates that cell death of neural crest cells is requisite for the smaller heads seen after lateral hybridoma injection.
Discussion
Sonic hedgehog is well recognized as an inductive signal for the formation of ventral midline of the neural tube and posterior limb bud, but its role in cell survival and proliferation has not been fully appreciated. We demonstrate that reducing Shh signaling has a dramatic effect on development of the cranial neural tube and branchial arches, primarily because of increased cell death, which leads to an overall reduction in head size. Two hours after injection into the head mesenchyme, floorplate cells bound antiShh antibody. There was no apparent loss of floorplate, however, even in severely affected embryos (data not Previous experiments have examined the effect of reducing or removing Shh early in development. Shh null mice have a variety of defects, including the loss of branchial arches and their derivatives [4] . Treatment of chick embryos at stage 4 with Shh-blocking alkaloid inhibitors results in a variety of head phenotypes, including complete cyclopia, which is thought to occur when the eye field fails to divide under the influence of the prechordal plate [13, 14] . Both the mouse and chicken phenotypes have been likened to the human developmental defect holoprosencephaly, the most severe cases having cyclopia [24] . Cyclopia was not observed in our study, presumably because bilateral eye fields have already separated by the time of Shh perturbation, or because insufficient neural crest cells are deleted by this treatment. Neither cyclopia nor head size reduction were seen with a single alkaloid treatment initiated at stage 10 rather than stage 4 (our unpublished observations) [13] . But multiple injections of cyclopamine into avian embryos starting at stage 10 resulted in a reduction in head size that was similar to that seen with function-blocking antibodies (our unpublished observations).
The loss of facial structures in the Shh mutant mouse and the craniofacial phenotypes of humans with holoprosencephaly cannot be completely reconciled with a simple loss of midline neural tube signaling. Neural crest cell death following inhibition of Shh signaling might explain the loss of the branchial arches and frontonasal mass tissues seen in the mouse knockout, and the facial dysmorphism seen in some of the patients with loss of a single copy of SHH. Reducing Shh signaling after the establishment of bilateral head structures still results in significant defects. This indicates that there is a continued requirement for Shh signaling in the growth and development of the head. Our results suggest that Shh might play two important roles in neural tube development -an early patterning role and a later proliferative/survival function. This does not, however, rule out subsequent roles for Shh in head development and patterning [25] .
The surviving neural crest cells appeared to contribute to the formation of structures derived from the neural crest, such as mandible and maxilla, because these were visible in the surviving older embryos. These were smaller both in the short term (1 day after injection) and in the long term (7 days after injection) suggesting that, although the residual neural crest cells patterned the facial structures correctly (Figure 3) , they did not compensate for the early reduction in cell number. Thus, the reduction in head size was probably due to inadequate numbers of neural crest cells, rather than to a developmental delay or other patterning effect.
Because the decrease in head size correlates with significant death of neural crest cells, the neural crest appears to be the primary determinant of head size at the stage examined. Given that the neural crest comprises most of the skeletal elements of the face, this is not unexpected. Noden [26] has shown that neural crest cells are responsible for patterning the head mesoderm. Neural crest cells might not only pattern the mesodermal cells of the head, but might also be involved in coordinating their size to match that of neural-crest-derived structures. Such coordinate regulation of cell number in the control of tissue size probably occurs through a combination of cell proliferation and survival [27] . Cell death in the neural tube alone was not sufficient to account for the decrease in head size 24 hours after hybridoma injection, although it undoubtedly played a role in the decreased head size at later timepoints.
There is a precedent for Shh being involved in the control of cell proliferation and cell survival [18] [19] [20] [21] . The notochord secretes factors (including Shh) that are responsible, not only for the organization of ventral cell types, but also for cell proliferation and survival. Notochord grafts next to chick neural tubes result in increased neuroblast proliferation [28] , whereas genetic or surgical removal of the notochord results in cell death in the neural tube [29, 30] . Thus, the role of Shh in the proliferation of the ventral neural tube is not unexpected, given the role that Shh plays in the control of cell fate of ventral progenitors [17, 31, 32] . The transient block of proliferation in the neural tube was restricted to ventral cells whereas the cell death was seen primarily in dorsal neural tube cells, suggesting that two separate cell types are affected by antiShh treatment in the neural tube. Death of dorsal neural tube cells might indicate that these cells directly need Shh to survive, which is consistent with their expression of the receptor gene Ptc [33] . To date, cell death in the neural tube and neural crest has not been reported for the Shh mutant mouse.
During normal development, many cell types are produced in excess and later eliminated by cell death resulting from a competition for survival factors [27] . Although we do not yet know whether Shh acts directly as a survival factor for migrating cranial neural crest cells, the finding that the reduction of Shh signal with blocking antibodies results in neural crest cell death suggests that Shh functions, either directly or indirectly, to regulate survival within this population. Unlike dorsal neural tube cells, early migrating cranial neural crest cells do not express either of the vertebrate Ptc genes [34, 35] , although the second receptor component, encoded by Smoothened (Smo), is ubiquitously expressed at low levels in most tissues during development [36] . Expression of Ptc in presumptive neural crest cells can only be seen at stages equivalent to those seen on the second day after injection (Figure 1g) , when, in normal embryos, Ptc is expressed in the mesenchyme of the branchial arch, in cells likely to be of neural crest origin. The Gli zinc-finger gene family is implicated in transduction of Shh signals, but these factors appear to be absent from migrating cranial neural crest cells [37] . This raises two interesting possibilities: first, that there are other molecules required for Shh signaling present in migrating cranial neural crest; or second, Shh effects on neural crest occur through an intermediate mechanism, possibly by regulating the expression of other survival or growth factors. Experiments described in this paper eliminate the neural tube as the source of survival factors for migrating neural crest cells, because removal of the neural tube and notochord after initiation of neural crest migration does not result in cell death of the migrating neural crest cells.
Cell death has not been previously described for migrating cranial neural crest, although both premigratory dorsal neural tube crest progenitors and postmigratory crest cell derivatives have been shown to die under a variety of conditions. In the hindbrain, it has been suggested that premigratory neural crest cells in rhombomeres three and five are depleted by apoptotic signals from adjacent, evennumbered rhombomeres [38] . The neural crest cell death described here is not the same, because anti-Shh treatment resulted in neural crest cell death all along the cranial neural axis, and in the streams of neural crest adjacent to the even-numbered rhombomeres (Figure 4a ). Mutant mice that lack both Wnt-1 and Wnt3a have reduced numbers of neural crest cells, but this reduction results from either a lack of proliferation or a cell death event that happens prior to neural crest migration [39] . Loss of AP-2, a transcription factor expressed in cranial neural crest cells, also results in cranial neural crest cell death, but of postmigratory neural crest cell populations [40, 41] .
Conclusions
Our data demonstrate that the anti-Shh antibody, applied after ventral midline induction, can phenocopy some of the notable features of holoprosencephaly, including profound reductions in head size. We show that the likely cause of the reduced head size is cell death of cranial neural crest cells during their migration to the branchial arches. Because neural crest cells are important for patterning the cranial mesoderm, we propose that the initial loss of neural crest cells might subsequently affect the size of structures in the head derived from the mesoderm and from the neural tube. These experiments are novel in that they establish, for the first time, that the severe loss of facial structures in holoprosencephaly are likely to result from a combination of effects of Shh on neural crest cells as well as an early effect on the ventral midline. Thus, our data show that Shh is involved in proliferation and survival of the cranial neural tube and neural crest. By acting to control cell division and survival in a variety of cell types in the head, Shh plays an important role in governing head size in addition to its well known role in patterning parts of the head. The data presented here provide a link between the cyclopia seen with a variety of defects in Shh signaling [4, 13, 14] and the cyclopia seen when cranial neural crest cells are ablated [8] [9] [10] .
Materials and methods
Cell culture
Hybridoma cells (both anti-Shh and QCPN) were obtained from the Developmental Studies Hybridoma Bank (Iowa City). Cells were grown in Isocoves modified media (Gibco) supplemented with 20% heat-inactivated fetal bovine serum and penicillin-streptomycin. Both antibodies used in this study are subtype IgG 1 .
Embryos
White Leghorn chicken eggs were incubated in a rocking incubator at 37°C with constant humidity until stages 9-11 (7-14 somite stage) of development [42] . A glass needle was placed at the midbrain-hindbrain level, and cells were pressure injected into the lateral head mesenchyme or into the neural tube. Ablations were performed on embryos at the 8-15 somite stage, using a fine glass needle to remove the desired area (dorsal neural tube or entire neural tube with or without the notochord). For quail-to-chick chimeras, the neural tube was ablated at the 7 somite stage, and then a quail neural tube of the same age was put in place, followed 4-6 h later with placement of the hybridoma cells. In all cases, the eggs were sealed with tape and replaced in a non-rocking incubator.
Whole-mount in situ hybridization
Whole-mount in situ hybridizations were performed as described previously [43] .
Head measurements
Embryos were collected and fixed at the desired time. The embryos were photographed at a fixed magnification on a dissecting microscope (Zeiss), with a calibrated graticule photographed at the same magnification. The measurements were made blind to treatment group by projecting slides of individual embryos on a screen, measuring the head dimensions, and converting the measurements using the graticule as a standard.
Fixation, whole-mount immunohistochemistry and sectioning
Embryos were fixed in 4% paraformaldehyde, rinsed, dehydrated in 100% methanol and stored at -20°. After rehydration, the embryos were bleached, rinsed and treated with proteinase K, refixed and blocked in 10% sheep serum. The secondary antibody used for wholemount immunohistochemistry was an alkaline-phosphatase-linked rabbit anti-mouse IgG 1 (Zymed), which was diluted 1:500 for use. The presence of the secondary antibody was detected using NBT/BCIP reaction product. For sectioning, embryos were immersed in a solution comprising 15% sucrose and 7.5% gelatin in PBS and then frozen. For immunohistochemistry, embryos were sectioned at -28°C, at 10-12 µm.
BrdU and cell death
Embryos were exposed to 10 -2 M 5-bromo-2′-deoxyuridine (BrdU; Sigma). Sections were processed for BrdU as described previously [44] . Sections were then counterstained with 10 µg/ml of the nuclear marker 4′,6-diamidino-2-phenylindole (DAPI; Sigma) in H 2 O for 10 min, and then mounted under a coverslip with Gel/Mount (Biomedia).
To detect cell death in live embryos, embryos were stained with a 1:50 solution of the membrane-impermeant dye, TO-PRO-1 iodide in DMEM (Molecular Probes) for 30 min at 37°C, followed by three washes in DMEM. The embryos were then visualized using a scanning confocal microscope (Biorad).
To determine the percentage of cell death in the neural crest, sections were stained with FITC-linked goat anti-mouse IgG (to localize hybridoma cells and visualize antibody spread), followed by 1:1 HNK-1 supernatant and then TRITC-goat anti mouse IgM. All antibodies were diluted in PBS/BSA. Sections were then counterstained with DAPI as described above. Pyknotic nuclei were counted relative to live nuclei with only clearly condensed or fragmented nuclei counted as dead.
Supplementary material
Supplementary material, including figures showing neural tube proliferation after anti-Shh treatment and the effects of hybridoma injection into the lateral mesenchyme or neural tube, is available at http://current-biology.com/supmat/supmatin.htm. 
